Tebu-Bio Laboratories To Offer Ligand Screening Services on PPAR Cell Lines

Didier Lecommandeur
tebu-bio today announced an agreement under which tebu-bio will license three PPAR cell lines from INSERM, the French National Institute for Health and Medical Research. The cell lines will be used for custom services. (PRWEB) September 16, 2005 -- tebu-bio laboratories announced that they have entered into an agreement with INSERM, the French National Institute for Health and Medical Research, under which tebu-bio will license for custom services three PPAR cell lines developed by Dr Patrick Balaguer at INSERM U540 in Montpellier. The peroxisome proliferator activated receptors (PPARs) are ligand-activated transcription factors that increase transcription of target genes by binding to a specific sequence in the gene's promoter. PPARs' role has been pointed out in several human diseases, such as diabetes, obesity, atherosclerosis, and the inflammatory response. The three cell lines are specific for each of the different PPAR isotypes (alpha, beta and gamma). By adding these reporter gene screening to its portfolio of services, the agreement strengthens tebu-bio's position as a pan-European provider of cutting-edge services for life sciences. About INSERM: The French National Institute for Health and Medical Research (INSERM) is a public scientific and technological organization. Overseen jointly by the French Ministries of Research and Health, INSERM's vocation is to promote health for all. About tebu-bio: tebu-bio is specialized in reagents and custom services in the field of life sciences. Our goal is to help scientists from academic and private laboratories succeed in their daily work by providing innovative tools adapted to their needs. Media Contact: Didier Lecommandeur tebu-bio laboratories Phone +33 (0)1 30 46 39 10



Additional Bio-Nanotechnology Articles

The Forum on Nanotechnology at the Biodesign Institute at Arizona State University Presents Sensing Single-Molecule Recognition with the Atomic Force Microscope
Given by Dr. Peter Hinterdorfer, Institute for Biophysics, Johannes Kepler University of Linz, Austria Co-sponsored by Molecular Imaging Tempe, AZ (PRWEB) March 16, 2005 -- The Biodesign Institute at Arizona...
Coordination and Biotech Research
One of the reasons why Africa and other poor regions of the world trail in crop biotechnology is lack of collaboration and coordination among scientists. There are millions of well-trained crop biotechnologists...
Will Nanotechnology Help Treat Cancer?
Cancer nanotechnology, the use of molecular tools designed to combat the disease, is a growing field. Recently, the National Cancer Institute announced two waves of funding for nanotech training and research,...
Briefing Document Nanobots Not Needed
The popular idea of so-called nanobots, powerful and at risk of running wild, is not part of modern plans for building things "atom-by-atom" by molecular manufacturing. Studies indicate that most people...